NYU Perlmutter Cancer Center — New York, New York

NYU Perlmutter Cancer Center is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

NYU Perlmutter Cancer Center has participated in 14 clinical trials with 2 currently active.

Therapeutic areas: Ovarian Cancer, NSCLC, ESCC.

Sponsors: Astellas Pharma Global Development, Inc., NYU Langone Health, Karyopharm Therapeutics Inc.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Perlmutter Cancer Center?

NYU Perlmutter Cancer Center has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Perlmutter Cancer Center conducted?

NYU Perlmutter Cancer Center has 14 clinical trials on record, with 2 currently active. Their work covers Ovarian Cancer, NSCLC, ESCC.

Is NYU Perlmutter Cancer Center accredited by Crixeo Health?

Yes — NYU Perlmutter Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about NYU Perlmutter Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.